A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Prognostic Significance of Arterial Lactate Levels at Weaning from Postcardiotomy Venoarterial Extracorporeal Membrane Oxygenation




TekijätFausto Biancari, Antonio Fiore, Kristján Jónsson, Giuseppe Gatti, Svante Zipfel, Vito G. Ruggieri, Andrea Perrotti, Karl Bounader, Antonio Loforte, Andrea Lechiancole, Diyar Saeed, Artur Lichtenberg, Marek Pol, Cristiano Spadaccio, Matteo Pettinari, Krister Mogianos, Khalid Alkhamees, Giovanni Mariscalco,
Zein El Dean, Nicla Settembre, Henryk Welp, Angelo M. Dell’Aquila, Thomas Fux, Tatu Juvonen, Magnus Dalén

KustantajaMDPI

Julkaisuvuosi2019

JournalJournal of Clinical Medicine

Tietokannassa oleva lehden nimiJOURNAL OF CLINICAL MEDICINE

Lehden akronyymiJ CLIN MED

Artikkelin numeroARTN 2218

Vuosikerta8

Numero12

Sivujen määrä10

eISSN2077-0383

DOIhttps://doi.org/10.3390/jcm8122218

Verkko-osoitehttps://www.mdpi.com/2077-0383/8/12/2218

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/45348408


Tiivistelmä
Background: The outcome after weaning from postcardiotomy venoarterial extracorporeal membrane oxygenation (VA-ECMO) is poor. In this study, we investigated the prognostic impact of arterial lactate levels at the time of weaning from postcardiotomy VA. Methods: This analysis included 338 patients from the multicenter PC-ECMO registry with available data on arterial lactate levels at weaning from VA-ECMO. Results: Arterial lactate levels at weaning from VA-ECMO (adjusted OR 1.426, 95%CI 1.157-1.758) was an independent predictor of hospital mortality, and its best cutoff values was 1.6 mmol/L (<1.6 mmol/L, 26.2% vs. >= 1.6 mmol/L, 45.0%; adjusted OR 2.489, 95%CI 1.374-4.505). When 261 patients with arterial lactate at VA-ECMO weaning <= 2.0 mmol/L were analyzed, a cutoff of arterial lactate of 1.4 mmol/L for prediction of hospital mortality was identified (<1.4 mmol/L, 24.2% vs. >= 1.4 mmol/L, 38.5%, p = 0.014). Among 87 propensity score-matched pairs, hospital mortality was significantly higher in patients with arterial lactate >= 1.4 mmol/L (39.1% vs. 23.0%, p = 0.029) compared to those with lower arterial lactate. Conclusions: Increased arterial lactate levels at the time of weaning from postcardiotomy VA-ECMO increases significantly the risk of hospital mortality. Arterial lactate may be useful in guiding optimal timing of VA-ECMO weaning.

Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 17:16